Highly cytotoxic osmium(ii) compounds and their ruthenium(ii) analogues targeting ovarian carcinoma cell lines and evading cisplatin resistance mechanisms

HIGHLIGHTS

  • who: Jana Hildebrandt et al. from the Institut für Anorganische und Analytische Chemie Friedrich-Schiller Universität Jena, Humboldtstraße, Department of Gynecology, Jena University Hospital-Friedrich-Schiller University Jena, Am Klinikum , have published the research work: Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms, in the Journal: (JOURNAL) of 27/04/2022
  • what: Focusing on structure-activity-relationships of this class of the authors report on 17 different ruthenium(II) complexes and four promising osmium(II) with cinnamic acid derivatives as . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?